168 related articles for article (PubMed ID: 36395596)
41. Pathologic features and biologic importance of colorectal serrated polyps.
Vakiani E; Yantiss RK
Adv Anat Pathol; 2009 Mar; 16(2):79-91. PubMed ID: 19550369
[TBL] [Abstract][Full Text] [Related]
42. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.
Yamane LS; Scapulatempo-Neto C; Alvarenga L; Oliveira CZ; Berardinelli GN; Almodova E; Cunha TR; Fava G; Colaiacovo W; Melani A; Fregnani JH; Reis RM; Guimarães DP
Oncol Rep; 2014 Oct; 32(4):1419-26. PubMed ID: 25050586
[TBL] [Abstract][Full Text] [Related]
43. Traditional serrated adenoma of the colorectum: clinicopathologic implications and endoscopic findings of the precursor lesions.
Kim MJ; Lee EJ; Suh JP; Chun SM; Jang SJ; Kim DS; Lee DH; Lee SH; Youk EG
Am J Clin Pathol; 2013 Dec; 140(6):898-911. PubMed ID: 24225759
[TBL] [Abstract][Full Text] [Related]
44. Endoscopic and molecular characterization of colorectal sessile serrated adenoma/polyps with cytologic dysplasia.
Tanaka Y; Yamano HO; Yamamoto E; Matushita HO; Aoki H; Yoshikawa K; Takagi R; Harada E; Nakaoka M; Yoshida Y; Eizuka M; Sugai T; Suzuki H; Nakase H
Gastrointest Endosc; 2017 Dec; 86(6):1131-1138.e4. PubMed ID: 28501592
[TBL] [Abstract][Full Text] [Related]
45. [Serrated, hyperplastic and hyperplasia-like colorectal polyps].
Folker MB; Bernstein IT; Holck S
Ugeskr Laeger; 2006 Nov; 168(46):4005-9. PubMed ID: 17125655
[TBL] [Abstract][Full Text] [Related]
46. Molecular characteristics of colorectal hyperplastic polyp subgroups.
Ünlü M; Uzun E; Bengi G; Sağol Ö; Sarıoğlu S
Turk J Gastroenterol; 2020 Aug; 31(8):573-580. PubMed ID: 32915145
[TBL] [Abstract][Full Text] [Related]
47. UK guidance for the pathological reporting of serrated lesions of the colorectum.
Bateman AC; Shepherd NA
J Clin Pathol; 2015 Aug; 68(8):585-91. PubMed ID: 25934843
[TBL] [Abstract][Full Text] [Related]
48. Increased Colorectal Neoplasia Risk in Patients with Inflammatory Bowel Disease and Serrated Polyps with Dysplasia.
de Jong ME; Nagtegaal ID; Vos S; van der Post RS; van Herwaarden Y; Derikx LAAP; Hoentjen F
Dig Dis Sci; 2022 Dec; 67(12):5647-5656. PubMed ID: 35380348
[TBL] [Abstract][Full Text] [Related]
49. Traditional serrated adenoma: an update.
Bettington ML; Chetty R
Hum Pathol; 2015 Jul; 46(7):933-8. PubMed ID: 26001333
[TBL] [Abstract][Full Text] [Related]
50. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis.
Caruso M; Moore J; Goodall GJ; Thomas M; Phillis S; Tyskin A; Cheetham G; Lerda N; Takahashi H; Ruszkiewicz A
Virchows Arch; 2009 Mar; 454(3):291-302. PubMed ID: 19172291
[TBL] [Abstract][Full Text] [Related]
51. Evolving pathologic concepts of serrated lesions of the colorectum.
Kim JH; Kang GH
J Pathol Transl Med; 2020 Jul; 54(4):276-289. PubMed ID: 32580537
[TBL] [Abstract][Full Text] [Related]
52. Beta-catenin nuclear labeling is a common feature of sessile serrated adenomas and correlates with early neoplastic progression after BRAF activation.
Yachida S; Mudali S; Martin SA; Montgomery EA; Iacobuzio-Donahue CA
Am J Surg Pathol; 2009 Dec; 33(12):1823-32. PubMed ID: 19745699
[TBL] [Abstract][Full Text] [Related]
53. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
[TBL] [Abstract][Full Text] [Related]
54. The histologic features, molecular features, detection and management of serrated polyps: a review.
Wang JD; Xu GS; Hu XL; Li WQ; Yao N; Han FZ; Zhang Y; Qu J
Front Oncol; 2024; 14():1356250. PubMed ID: 38515581
[TBL] [Abstract][Full Text] [Related]
55. Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas.
Burnett-Hartman AN; Newcomb PA; Potter JD; Passarelli MN; Phipps AI; Wurscher MA; Grady WM; Zhu LC; Upton MP; Makar KW
Cancer Res; 2013 May; 73(9):2863-72. PubMed ID: 23539450
[TBL] [Abstract][Full Text] [Related]
56. IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions.
Naito T; Nosho K; Ito M; Igarashi H; Mitsuhashi K; Yoshii S; Aoki H; Nomura M; Sukawa Y; Yamamoto E; Adachi Y; Takahashi H; Hosokawa M; Fujita M; Takenouchi T; Maruyama R; Suzuki H; Baba Y; Imai K; Yamamoto H; Ogino S; Shinomura Y
World J Gastroenterol; 2014 Aug; 20(29):10050-61. PubMed ID: 25110432
[TBL] [Abstract][Full Text] [Related]
57. Agrin in the Muscularis Mucosa Serves as a Biomarker Distinguishing Hyperplastic Polyps from Sessile Serrated Lesions.
Rickelt S; Condon C; Mana M; Whittaker C; Pfirschke C; Roper J; Patil DT; Brown I; Mattia AR; Zukerberg L; Zhao Q; Chetty R; Lauwers GY; Neyaz A; Leijssen LGJ; Boylan K; Yilmaz OH; Deshpande V; Hynes RO
Clin Cancer Res; 2020 Mar; 26(6):1277-1287. PubMed ID: 31852835
[TBL] [Abstract][Full Text] [Related]
58. Serrated polyps with "intermediate features" of sessile serrated polyp and microvesicular hyperplastic polyp: a practical approach to the classification of nondysplastic serrated polyps.
Chung SM; Chen YT; Panczykowski A; Schamberg N; Klimstra DS; Yantiss RK
Am J Surg Pathol; 2008 Mar; 32(3):407-12. PubMed ID: 18300810
[TBL] [Abstract][Full Text] [Related]
59. Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans.
Rosenberg DW; Yang S; Pleau DC; Greenspan EJ; Stevens RG; Rajan TV; Heinen CD; Levine J; Zhou Y; O'Brien MJ
Cancer Res; 2007 Apr; 67(8):3551-4. PubMed ID: 17440063
[TBL] [Abstract][Full Text] [Related]
60. Endoscopic diagnosis for colorectal sessile serrated lesions.
Nishizawa T; Yoshida S; Toyoshima A; Yamada T; Sakaguchi Y; Irako T; Ebinuma H; Kanai T; Koike K; Toyoshima O
World J Gastroenterol; 2021 Apr; 27(13):1321-1329. PubMed ID: 33833485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]